Publication: The impact of visible tumor (PI-RADS >= 3) on upgrading and adverse pathology at radical prostatectomy in low risk prostate cancer patients: a biopsy core based analysis
Program
KU Authors
Co-Authors
Kilic, Mert
Saglican, Yesim
Tugcu, Volkan
Bakir, Baris
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Deciding on the management of prostate cancer (PCa), especially GG1 PCa, is quite difficult. The most important thing that will help us in making active surveillance or definitive treatment decision is whether the tumor is a clinically significant tumor. To understand this, we discussed in this article that multiparametric MR, PI-RADS scoring and targeted biopsy can be used. Background
Source
Publisher
Cig Media Group, Lp
Subject
Oncology, Urology, Nephrology
Citation
Has Part
Source
Clinical Genitourinary Cancer
Book Series Title
Edition
DOI
10.1016/j.clgc.2021.09.007
item.page.datauri
Link
Rights
N/A